Complete your stack
- Clenbuterol $95
- Cytomel (T3) $95
- Tirzepatide $140
Semaglutide (Ozempic)
$120
Semaglutide is a GLP-1 receptor agonist (Ozempic and Wegovy) researched for appetite suppression, weight loss and blood-glucose control.
- Lyophilised powder for reconstitution
- Research Dose: 0.25-2.4 mg
- Frequency: Once weekly (subcutaneous)
- Cycle Duration: 12-16+ weeks, titrated
- Stack With: Cagrilintide or Tirzepatide
Description
Buy Semaglutide (Ozempic) in Canada from Legacy Laboratories. Semaglutide is a long-acting GLP-1 receptor agonist and one of the most extensively studied metabolic peptides in the world, marketed pharmaceutically as Ozempic, Wegovy, and Rybelsus.
What Is Semaglutide?
Semaglutide mimics the incretin hormone GLP-1. See its DrugBank entry for full pharmacology.
How Semaglutide Works
By activating GLP-1 receptors, Semaglutide increases glucose-dependent insulin secretion, slows gastric emptying, and acts on appetite centres in the brain to reduce hunger and food intake.
Research & Potential Benefits
- Substantial, sustained weight loss (STEP trials)
- Improved blood-glucose and HbA1c control (SUSTAIN trials)
- Reduced cardiovascular risk markers in clinical research
Review the evidence on PubMed.
Stacking Semaglutide
Semaglutide is commonly researched with Cagrilintide (the “CagriSema” combination) and compared with Tirzepatide.
Important Information
The information above is provided for educational and research purposes only and has not been evaluated by Health Canada or the U.S. Food & Drug Administration. Products are not intended to diagnose, treat, cure, or prevent any disease. Semaglutide and Tirzepatide are prescription medications in many jurisdictions; nothing here is medical advice. Always consult a licensed healthcare professional before beginning any new compound.
Complete Your Stack
Frequently bought together — add all and unlock VIP pricing.
